JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gastroenterology

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0016-5085(03)00904-1PMID 12891558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.

  2003cited by this paper
• Induction of Cyclooxygenase‐2 in Ras‐Transformed Human Mammary Epithelial Cells Undergoing Apoptosis

  2002cited by this paper
• Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

  2002cited by this paper
• Differential expression of cyclooxygenase‐2 (COX‐2) in human bile duct epithelial cells and bile duct neoplasm

  2001cited by this paper
• Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

  2001cited by this paper
• Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.

  2001cited by this paper
• Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells.

  2001cited by this paper
• Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.

  2001cited by this paper
• Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.

  2000cited by this paper
• mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats.

  2000cited by this paper
• Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.

  2000cited by this paper
• Prevention of cross-contamination during sampling procedure in molecular detection for cancer micrometastasis.

  2000cited by this paper
• Chemoprevention by Nimesulide, a Selective Cyclooxygenase‐2 Inhibitor, of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐induced Mammary Gland Carcinogenesis in Rats

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

  2000cited by this paper
• Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.

  1999cited by this paper
• Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases.

  1999cited by this paper
• Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

  1999cited by this paper
• Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet.

  1999cited by this paper
• Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.

  1999cited by this paper
• Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation

  1999cited by this paper
• Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice.

  1999cited by this paper
• Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells

  1999cited by this paper
• Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells

  1999cited by this paper
• Cancer statistics, 1998

  1998cited by this paper
• Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

  1998cited by this paper
• Meloxicam inhibits the growth of colorectal cancer cells.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats.

  1998cited by this paper
• Profile of JTE-522 as a human cyclooxygenase-2 inhibitor.

  1998cited by this paper
• Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

  1998cited by this paper
• Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.

  1997cited by this paper
• Natural history of hepatitis C

  1997cited by this paper
• Choline deficiency causes increased localization of transforming growth factor-beta1 signaling proteins and apoptosis in the rat liver.

  1997cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide.

  1995cited by this paper
• Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages.

  1995cited by this paper
• Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats.

  1994cited by this paper
• Increased Cell Proliferation of Azoxymethane‐induced Aberrant Crypt Foci of Rat Colon

  1994cited by this paper
• Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

  1994cited by this paper
• Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

  1993cited by this paper
• Nonsteroidal anti-inflammatory drug toxicity.

  1993cited by this paper
• The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies

  1993cited by this paper
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• Differential expression of hepatocyte growth factor, transforming growth factor‐α and transforming growth factor‐β1 messenger RNAs in two experimental models of liver cell proliferation

  1992cited by this paper
• Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.

  1992cited by this paper
• Human cyclooxygenase-2 cDNA.

  1992cited by this paper
• Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

  1991cited by this paper
• Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly.

  1991cited by this paper
• Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo.

  1990cited by this paper
• Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine.

  1990cited by this paper
• c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet.

  1989cited by this paper
• Single GST-P positive liver cells--putative initiated hepatocytes.

  1987cited by this paper
• Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis.

  1985cited by this paper
• Purification with monoclonal antibody of a predominant leukocyte‐common antigen and glycoprotein from rat thymocytes

  1979cited by this paper
• Report of a workshop on classification of specific hepatocellular lesions in rats.

  1975cited by this paper

• Construction of Biaryl Sulfonamides via Pd(II)-Catalyzed Cross-Coupling of C(sp2)-H Bonds with Iodobenzenesulfonamides

  2025cites this paper
• Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.

  2024cites this paper
• Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma

  2024cites this paper
• Diverse role, structural trends, and applications of fluorinated sulphonamide compounds in agrochemical and pharmaceutical fields

  2024cites this paper
• Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma

  2023cites this paper
• Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy

  2023cites this paper
• Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.

  2023cites this paper
• The phenolic compounds of ethanolic extract of date seed (Phoenix dactylifera L.) exert hepatoprotective activity on rat induced carragenan

  2022cites this paper
• Molecular interplay promotes amelioration by quercetin during experimental hepatic inflammation in rodents.

  2022cites this paper
• Aspirin and Infection: A Narrative Review

  2022cites this paper
• Involvement of TLR4 signaling regulated-COX2/PGE2 axis in liver fibrosis induced by Schistosoma japonicum infection

  2021cites this paper
• Role of eicosanoids in liver repair, regeneration and cancer.

  2021cites this paper
• Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.

  2020cites this paper
• Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma

  2019cites this paper
• Developmental perspectives of the drugs targeting enzyme-instigated inflammation: a mini review

  2019cites this paper
• COX-2/iNOS regulation during experimental hepatic injury and its mitigation by cloudy apple juice.

  2019cites this paper
• Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression

  2018cites this paper
• Resveratrol attenuates Nitrosodiethylamine-induced liver injury in anti-inflammatory manner via regulating cyclooxygenase-2

  2018cites this paper
• Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer

  2018cites this paper
• Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β

  2017cites this paper
• Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer

  2017cites this paper
• Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection

  2017cites this paper
• The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma

  2016cites this paper
• Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer

  2016cites this paper
• The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity

  2016cites this paper
• Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial

  2016cites this paper
• Hepatotoxicity induced by coxibs: how concerned should we be?

  2016cites this paper
• Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy

  2016cites this paper
• Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats

  2016cites this paper
• Papel de las prostaglandinas producidas por la ciclooxigenasa-2 en la resistencia a la insulina asociada a la enfermedad hepática grasa no alcohólica

  2016cites this paper
• Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling

  2015cites this paper
• Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma.

  2015cites this paper
• Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer

  2015cites this paper
• Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.

  2014cites this paper
• Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma.

  2014cites this paper
• Decreased miR-340 expression in bone marrow is associated with liver metastasis

  2014cites this paper
• Companion Diagnostic and Cancer Biomarkers Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

  2014cites this paper
• Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.

  2014cites this paper
• Gadoxetic Acid-Enhanced MRI and Sonoelastography: Non-Invasive Assessments of Chemoprevention of Liver Fibrosis in Thioacetamide-Induced Rats with Sho-Saiko-To

  2014cites this paper
• Title Tumor cyclooxygenase-2 levels correlate with tumorinvasiveness in human hepatocellular carcinoma

  2014cites this paper
• Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

  2014cites this paper
• Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt

  2014cites this paper
• The role of inflammation and liver cancer.

  2014cites this paper
• Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis

  2013cites this paper
• Distinct expression of C4.4A in colorectal cancer detected by different antibodies.

  2013cites this paper
• Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.

  2013cites this paper
• miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

  2013cites this paper
• Inhibition of angiopoietin 2 attenuates lumen formation of tumour-associated vessels in vivo.

  2013cites this paper
• Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride–associated hepatotoxicity in rats

  2013cites this paper
• Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression.

  2013cites this paper
• Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.

  2013cites this paper
• Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer.

  2013cites this paper
• Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome

  2012cites this paper
• microRNA-181 a is associated with poor prognosis of colorectal cancer

  2012cites this paper
• Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4

  2012cites this paper
• Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats

  2012cites this paper
• microRNA-181a is associated with poor prognosis of colorectal cancer.

  2012cites this paper
• Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells

  2012cites this paper
• MicroRNA-372 Is Associated with Poor Prognosis in Colorectal Cancer

  2012cites this paper
• C4.4A is associated with tumor budding and epithelial–mesenchymal transition of colorectal cancer

  2012cites this paper
• Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection

  2012cites this paper
• Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma

  2012cites this paper
• SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.

  2012cites this paper
• Meloxicam Modulates Oxidative Stress Status, Inhibits Prostaglandin E2, and Abrogates Apoptosis in Carbon Tetrachloride–Induced Rat Hepatic Injury

  2012cites this paper
• Selective cyclooxygenase-2 inhibitor prevents cisplatin-induced tumorigenesis in A/J mice.

  2012cites this paper
• The Significance of PITX2 Overexpression in Human Colorectal Cancer

  2011cites this paper
• Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis.

  2011cites this paper
• Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway.

  2011cites this paper
• Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor‐beta‐induced activation of rat hepatic stellate cells

  2011cites this paper
• Current progress in antifibrotics.

  2011cites this paper
• Molecular targets in the design of antifibrotic therapy in chronic liver disease.

  2011cites this paper
• Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer

  2010cites this paper
• Serum vascular endothelial growth factor per platelet count in patients with biliary atresia

  2010cites this paper
• Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat

  2010cites this paper
• Cyclooxygenase-2 gene -1195G/A genotype is associated with the risk of HBV-induced HCC: A case-control study in Han Chinese people

  2010cites this paper
• Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells

  2010cites this paper
• Paper de la 2-ciclooxigenasa i la 5-lipooxigenasa en la inflamació hepàtica i del teixit adipós

  2010cites this paper
• onji Domain Containing 1A Is a Novel Prognostic Marker Colorectal Cancer: In vivo Identification from R oxic Tumor Cells

  2010cites this paper
• Effect of the Selective Cyclooxygenase-2 Inhibition by HNHA [ N-hydroxy-7-(2-naphthylthio) heptanomide]on Liver Fibrosis in the Bile Duct Ligated Rat.

  2010cites this paper
• Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.

  2010cites this paper
• Re: Inability of celecoxib to prevent fibrosis in bile duct‐ligated rat liver

  2009cites this paper
• Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors

  2009cites this paper
• The anti‐inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct‐ligated rats

  2009cites this paper
• Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats

  2009cites this paper
• Inability of celecoxib to prevent fibrosis in bile duct‐ligated rat liver

  2009cites this paper
• Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane.

  2009cites this paper
• Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury.

  2008cites this paper
• [Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators].

  2008cites this paper
• Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy

  2008cites this paper
• Overexpression of connexin 26 in carcinoma of the pancreas.

  2008cites this paper
• LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers.

  2008cites this paper
• Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer

  2008cites this paper
• Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.

  2008cites this paper
• Mecanismos básicos de lesión hepatocelular. Papel de los mediadores lipídicos de inflamación

  2008cites this paper
• Advances in drug treatment of portal hypertension

  2008cites this paper
• Cyclooxygenase‐2: its paradoxical roles in liver inflammation and fibrosis

  2008cites this paper
• Effect of selective cyclooxygenase‐2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts

  2008cites this paper
• A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer

  2007cites this paper
• Papel de los mediadores lipídicos derivados del ácido araquidónico en la inflamación y la fibrogénesis hepática

  2007cites this paper
• Protection against Fas‐induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes

  2007cites this paper